Doctors inclined to prescribe new Alzheimer’s drug despite concerns

Jared Whitlock

Features Editor

Beth Snyder Bulik

Senior Editor

Doctors who treat Alzheimer’s patients say they’re likely to prescribe Eisai and Biogen’s new therapy approved Friday, but sounded notes of caution over the lack …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Doctors inclined to prescribe new Alzheimer’s drug despite concerns

Jared Whitlock

Features Editor

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Are programs with compounded GLP-1s safe for your population?

Doc­tors in­clined to pre­scribe new Alzheimer’s drug de­spite con­cerns

Features Editor

Senior Editor

Sign up to read this article for free.

Doctors inclined to prescribe new Alzheimer’s drug despite concerns